|
1) |
Rodriguez RR, et al. High dose rate brachytherapy for prostate cancer. Assessment of current clinical practice and the recommendation of the American brachytherapy society. J of Brachytherapy International. 2001;17:265-82. |
2) |
RTOG homepage http://www.rtog.org |
3) |
Jo Y, Hiratsuka J, Fujii T, et al. High-dose-rate iridium-192 afterloading therapy combined with external beam radiotherapy for T1c-T3bN0 M0 prostate cancer. Urology. 2004 Sep;64(3):556-60. |
4) |
Hiratsuka J, Jo Y, Yoshida K, et al. Clinical results of combined treatment conformal high-dose-rate iridium-192 brachytherapy and external beam radiotherapy using staging lymphadenectomy for localized prostate cancer. Int J Radiat Oncol Biol Phys. 2004;59(3):684-90. |
5) |
Egawa S, Shimura S, Irie A, et al. Toxicity and health-related quality of life during and after high dose rate brachytherapy followed by external beam radiotherapy for prostate cancer. Jpn J Clin Oncol. 2001;31(11):541-7. |